Market Overview
The Europe Respiratory Monitoring Market covers a wide range of devices including spirometers, pulse oximeters, capnographs, peak flow meters, and connected multi-parameter monitors used in both clinical and home settings. Valued at around $9.88 billion in 2025, the market is forecast to expand at a 7.15% CAGR through the end of the decade. Demand is supported by the high prevalence of chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and post-infectious respiratory complications across Western, Central, and Eastern Europe.
- •Market valued at approximately $9.88 billion in 2025, growing at 7.15% annually.
- •Key device categories include spirometers, pulse oximeters, capnographs, and wearable respiratory monitors.
- •Western European countries account for the largest share of regional revenue.
Growth Drivers
Rising incidence of chronic respiratory conditions such as COPD and asthma is the principal demand driver, alongside Europe’s steadily aging demographic, which increases the need for continuous lung-function monitoring. Greater emphasis on early diagnosis, value-based care, and remote patient management is accelerating adoption of portable and connected monitoring devices. Reimbursement support for home-care respiratory equipment in major EU economies further reinforces market expansion.
- •Rising prevalence of COPD, asthma, and sleep apnea across the region.
- •Aging European population increasing demand for long-term respiratory care.
- •Reimbursement frameworks supporting home-based and remote monitoring.
Segmentation and Regional Analysis
The market is segmented by device type, application, end-user, and geography. Therapeutic and diagnostic monitoring devices serve hospitals, ambulatory care centers, and home-care settings, with hospital use still representing the largest revenue segment. Geographically, Germany, the United Kingdom, France, Italy, and Spain lead the region, while Nordic countries are emerging adopters of digital and remote monitoring solutions.
- •Hospitals remain the largest end-user segment, followed by home-care and ambulatory settings.
- •Germany, the UK, France, Italy, and Spain dominate regional revenue.
- •Nordic and Benelux markets show the fastest uptake of connected and remote monitoring.
Trends and Outlook
What are the recent trends and outlook?
Key trends shaping the outlook include miniaturization of sensors, AI-enabled interpretation of respiratory data, and deeper integration with telehealth platforms that allow clinicians to monitor patients remotely. Wearable and patch-style monitors are moving from hospital use into consumer health, supported by smartphone compatibility and cloud analytics. Looking ahead, the market is expected to benefit from expanded home-care reimbursement, public health investment in respiratory care, and continued digital transformation of European health systems.
- •AI-driven analytics and wearable sensors are transforming respiratory care delivery.
- •Telehealth integration is expanding remote monitoring for chronic respiratory patients.
- •Continued investment in home-care infrastructure supports sustained market growth through 2030.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.